Urology Times Podcasts / Dr. Schuster highlights the FDA approval of imaging agent flotufolastat F 18 in prostate cancer

View our embed guidelines

Sorry, your browser isn't supported.

We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.

You can visit our support center if you're having problems.